Jasper Therapeutics, Inc. (JSPR:NASDAQ) closed at $0.511 on November 4, 2026, up 6.48% on the day. The stock trades 78.9% below its 52-week high of $2.42 and 62.3% above its 52-week low of $0.315. Over the past year, it lost 72.1%. Jasper Therapeutics, Inc. is part of the Finance sector.
In 252 trading sessions since November 4, 2025, JSPR closed higher on 117 days (46%). Its best day was June 29, 2026 (+23.17%) and its worst was June 1, 2026 (-35.59%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 3 times.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Find more stocks like JSPR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.